As of Feb 18, 2025, Johnson & Johnson Intrinsic Value is $194.5. This suggests it may be undervalued by 25.3% compared to its current price of around $155.3.
As of Feb 18, 2025, Johnson & Johnson's Discounted Cash Flow (DCF) valuation estimates its share price at $228.0. This suggests it may be overvalued by 46.9% to its current price of around $155.3, using a discount rate of 7.1% and terminal growth rate of 3.0%.
Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $194.5, compared to a market price of around $155.3. This suggests a potential undervaluation of 25.3%.